The Liposome Company, Inc.
117Patents
0Active
117Granted
43Portfolio score
Filing activity: Mar 24, 1983 → Oct 11, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4522803A | Stable plurilamellar vesicles, their preparation and use | Emerging Cross-Sectional Technologies | 276 | Expired |
| US5008050A | Extrusion technique for producing unilamellar vesicles | Emerging Cross-Sectional Technologies | 239 | Expired |
| US5204112A | Induction of asymmetry in vesicles | Emerging Cross-Sectional Technologies | 218 | Expired |
| US4708861A | Liposome-gel compositions | Emerging Cross-Sectional Technologies | 216 | Expired |
| US5077056A | Encapsulation of antineoplastic agents in liposomes | Emerging Cross-Sectional Technologies | 204 | Expired |
| US4610868A | Lipid matrix carriers for use in drug delivery systems | Emerging Cross-Sectional Technologies | 201 | Expired |
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US4588578A | Lipid vesicles prepared in a monophase | Emerging Cross-Sectional Technologies | 183 | Expired |
| US5399331A | Method for protein-liposome coupling | Human Necessities | 162 | Expired |
| US5169637A | Stable plurilamellar vesicles | Emerging Cross-Sectional Technologies | 146 | Expired |
| US5552155A | Fusogenic lipsomes and methods for making and using same | Emerging Cross-Sectional Technologies | 142 | Expired |
| US4721612A | Steroidal liposomes | Emerging Cross-Sectional Technologies | 136 | Expired |
| US4975282A | Multilamellar liposomes having improved trapping efficiencies | Human Necessities | 126 | Expired |
| US4981692A | Therapeutic treatment by intramammary infusion | Emerging Cross-Sectional Technologies | 123 | Expired |
| US5948441A | Method for size separation of particles | Emerging Cross-Sectional Technologies | 115 | Expired |
| US5059421A | Preparation of targeted liposome systems of a defined size distribution | Human Necessities | 112 | Expired |
| US5154930A | Pharmacological agent-lipid solution preparation | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5030453A | Stable plurilamellar vesicles | Human Necessities | 102 | Expired |
| US5736155A | Encapsulation of antineoplastic agents in liposomes | Human Necessities | 101 | Expired |
| US6090406A | Potentiation of immune responses with liposomal adjuvants | Emerging Cross-Sectional Technologies | 100 | Expired |
| US5059591A | Drug preparations of reduced toxicity | Human Necessities | 100 | Expired |
| US5000958A | Enhancement of pharmaceutical activity | Emerging Cross-Sectional Technologies | 90 | Expired |
| US6759057B1 | Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5795589A | Liposomal antineoplastic agent compositions | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5100662A | Steroidal liposomes exhibiting enhanced stability | Emerging Cross-Sectional Technologies | 79 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.